Additional file 1 of METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis

Supplementary Material 1 (Table S1–S4): Gene expression data correlated with clinical information, sequencing data, and mass spectometry data. Table S1: METTL3/CYP19A1 expression of TMA data from 84 NSCLC patients; Table S2: METTL3 expression in DIA-MS data from a late-stage NSCLC cohort (PMID 34870237); Table S3: Genes in each group of the venn diagram in Figure 4C; Table S4: List of mass spectrometry data of each group in Figure 7A